domingo, 26 de abril de 2020

BioEdge: Is a Texas nursing home doctor abusing human rights?

BioEdge: Is a Texas nursing home doctor abusing human rights?

Bioedge


Is a Texas nursing home doctor abusing human rights?
    


The medical director of a nursing home in Texas has come under fire for giving the anti-malaria drug hydroxychloroquine to coronavirus-positive elderly patients and tracking the outcomes in an "observational study."
The medication has been touted by President Trump and by numerous internet sites, but medical scientists are very sceptical. Although there are several clinical trials being conducted in a desperate effort to identify drugs which will treat the disease, the Food and Drug Administration has not approved hydroxychloroquine for Covid-19.
However, Dr Robin Armstrong, of The Resort, a nursing home in Texas City, near Galveston, gave the drug to dozens of patients after more than half of the 135 residents and more than 30 staff tested positive.
Critics say that there are many ethical problems with Dr Armstrong’s approach. DePaul University bioethicist Craig Klugman writes scathingly:
His “observational study” echoes language used to justify the Tuskegee Study and the Guatemala Syphilis Studies. And Armstrong’s work shares many of the same faults but is more poorly designed. He reports, “It’s actually going well. People are getting better.” Of course, he hasn’t stated what “getting better” means. Nor has he provided any information on what data is being collected, what doses of medication are being used, or what records are being kept. If this is indeed a real trial, then why is it not listed at clinicaltrials.gov?
He even calls for Dr Armstrong to be investigated by police and suspended by the Texas Medical Board. “This case will probably join the annals of human subjects research abuse trials that are a mainstay of responsible conduct of research courses.”
There’s a political angle to the controversy. Dr Armstrong is a staunch and well-connected Republican who used his links with prominent politicians to obtain a stock of hydroxychloroquine.
The merits of the drug have been bandied about in the media, especially after the President expressed his enthusiasm about its possibilities. But scientists are far more circumspect.
"We know the right dosages for malaria and lupus and rheumatoid arthritis but don't know yet what the right dosages are [for Covid-19], that's why we are doing clinical trials to make sure we get it right," Katherine Seley-Radtke, a coronavirus expert at the University of Maryland, told NPR. "I just find it amazing that everybody, including the President, thinks that this is just no big deal to go ahead and take this."
Michael Cook is editor of BioEdge
Bioedge

I'm not sure who was the first to say, "“Never let a good crisis go to waste". But lots of people are taking this wisdom to heart in the Covid-19 pandemic. It's a time when unconventional ideas may get a warmer welcome than usual because of the fear and the sense of urgency in the air. Perhaps that's why organ donation euthanasia sounds a bit more plausible if Covid-19 victims are doing the donating. See the report below.  
NEWS THIS WEEK
by Michael Cook | Apr 26, 2020
Two bioethicists argue that victims can offer their bodies for experimentation and organ donation
 
 
by Michael Cook | Apr 26, 2020
A lifespan approach to bioethics
 
 
by Michael Cook | Apr 26, 2020
He has been giving the anti-malaria drug hydroxychloroquine to coronavirus-positive elderly patients
 
 
by Michael Cook | Apr 26, 2020
It might save lives but it tests the bounds of privacy
 
 
by Michael Cook | Apr 26, 2020
A British judge has ruled that a woman should be fitted with an IUD
 
 
by Xavier Symons | Apr 25, 2020
Patients need not be competent to be euthanised.
 
 
by Michael Cook | Apr 25, 2020
Neglect of nursing homes is a “humanitarian crisis”.     
Bioedge

BioEdge
Level 1, 488 Botany Road, Alexandria NSW 2015 Australia
Phone: +61 2 8005 8605
Mobile: 0422-691-615

No hay comentarios: